Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nuobai Pharmaceutical is a comprehensive pharmaceutical enterprise based in Zhejiang, China, specializing in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company operates advanced manufacturing facilities that adhere to international GMP standards, enabling it to supply high-quality generic medications to both domestic and global markets. Its core therapeutic focus includes cardiovascular health, anti-infectives, and gastrointestinal disorders, with a portfolio featuring widely used treatments like statins and anticoagulants. Nuobai is recognized for its expertise in complex chemical synthesis and provides contract manufacturing and development services to international partners. The company maintains a strong emphasis on regulatory compliance and quality control to ensure the safety and efficacy of its pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuobai Pharm.